Company Structure

Roche’s operating businesses are organised into two divisions:

Innovation has been one of Roche's hallmarks ever since, and many of our pharmaceutical products have become milestones in drug therapy. Upon these products we built our present world leadership in the hospital pharmacy market.

Roche Pharmaceuticals

At Roche’s Pharmaceuticals Division, we view continuous innovation as the most promising way to bring new medicines to the patient. Looking to the future, our long-standing expertise in medicinal chemistry and biotechnology have put us in an excellent position to exploit the huge potential of molecular medicine.

Genentech

Genentech is a leading biotechnology company that develops, manufactures and commercializes pharmaceutical products for a variety of medical conditions. Based in South San Francisco, CA, Genentech has been a biotech pioneer for over 30 years. The company has a leading franchise in Oncology and also focuses on Immunology, Tissue Growth and Repair and Neuroscience. Genentech has one of the most diverse and robust portfolios in biotech.

Chugai

Chugai Pharmaceutical, specialised in prescription pharmaceuticals and based in Tokyo, is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Since the start of the strategic alliance with Roche in October 2002, Chugai has been actively involved in prescription pharmaceutical R&D activities in Japan and abroad as an important member of the Roche Group. Specifically, Chugai is working to develop innovative products with global applications, focusing on the disease areas of oncology, renal disease, and bone and joint.

Roche Applied Science

Roche Applied Science supplies a broad and growing array of instruments and highly specific reagents and test kits for use in the research market. Its product portfolio and capabilities are especially strong in genomics and proteomics, sciences that are transforming our understanding and the treatment of disease.

Roche Molecular Diagnostics

Roche Molecular Diagnostics develops and commercialises innovative, highly sensitive instrument systems and tests that reliably detect viruses and other pathogens in patient samples and in donated blood, tissues and organs. The business area is also working on new gene-based tests to improve the diagnosis and treatment of non-infectious diseases, with a focus on the areas of cancer and inflammatory disease.

Roche Professional Diagnostics

Roche Professional Diagnostics supplies instrument systems, tests, software and services that help clinical laboratories deliver reliable results more efficiently and cost-effectively. It is a leader in the growing market for point-of-care testing products to support clinical decision-making close to the patient, in doctors’ offices, emergency rooms and other primary and specialty care settings.

Roche Tissue Diagnostics

Ventana, a member of the Roche group, is the leading supplier of automated diagnostic systems to the anatomical pathology market. The instrument and reagent systems are used in clinical histology, cytology, and drug discovery laboratories around the globe. Through automation and systems integration, Ventana is standardising and optimising the slide staining process, thereby helping pathologists recommend treatment solutions that deliver superior patient care.

Roche Diabetes Care

Roche Diabetes Care’s products are all designed with the same basic aims in mind: to help people with diabetes live healthy, productive lives and to make managing diabetes easier. Monitoring systems with integrated lancets and test strips and software for storing and analysing data are an increasingly important part of Roche’s diabetes care portfolio because they improve glycemic (blood glucose) control for many users, in addition to offering greater convenience. Activities aimed at integrating glucose monitoring and data management with insulin delivery are ongoing and may one day result in systems that closely mimic the way the healthy pancreas regulates blood glucose levels.